Abstract
The complement system is an ancient element of innate immunity present at progressively more evolved forms in the blood or lymph of all vertebrates studied and in at least some invertebrate species (Nonaka 1998). It provides one of the best examples of an effective first line of host defense system. Complement can recognize conserved repetitive structural elements important for the survival of pathogens and therefore shared by large groups of them. Recognition leads to the activation of the system and elimination of the pathogens either by direct killing or by opsonophagocytosis and intracellular killing. In parallel, complement also provides signals to adaptive immunity instructing it to respond vigorously against pathogens (Carroll 1998; Fearon 1998). Furthermore, through its ability to discriminate between free and antigen-bound immunoglobulins, complement serves as an effector arm of adaptive humoral immunity leading to elimination of pathogens recognized by specific antibodies. Finally, complement appears to have a special relationship with natural antibodies depending on them for recognition of important pathogens and in turn providing signals for clonal selection and expansion of CD5+ B-1 cells that produce natural antibodies (Carroll and Prodeus 1998).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC (1996) Disruption of the Cr2 locus results in a reduction in B-la cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251–262
Ames RS, Li Y, Sarau HM (1996) Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271: 20231–20234
Arya S, Chen F, Spycher S, Isenman D, Shulman MJ, Painter RH (1994) Mapping of amino acid residues in the C1.13 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis. J Immunol 152: 1206–1212
Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg LA (1999) Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 96: 2250–2255
Bianco C, Griffin FM, Silverstein SC (1975) Studies on the macrophage complement receptor: alteration of receptor function upon macrophage activation. J Exp Mad 141: 1278–1290
Boettger EC, Metzger S, Bitter-Suermann D, Stevenson G, Kleindienst S, Burger R (1986) Impaired humoral immune response in complement C3-deficient guinea pigs: absence of a secondary immune response. Eur J Immunol 16: 1231–1235
Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-I and Leu-13 molecules. J Immunol 149: 2841–2850
Bredt W, Wellek B, Brunner H, Loos M (1977) Studies on the interaction between Mycoplasma pneumoniae and the first component of complement. Infect Immun 15: 7–12
Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16: 545–568
Carroll MC, Prodeus AP (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10: 36–40
Carter RH, Fearon DT (1992) CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105–107
Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM complex. J Immunol 141: 457–463
Clas F, Loos M (1981) Antibody-independent binding of the first component of complement and its subcomponent Clq to the S and R forms of Salmonella minnesota. Infect Immun 31: 1138–1144
Cooper NR, Morrison DC (1978) Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol 120: 1862–1868
Cooper NR, Jensen FC, Welsh RM, Oldstone MBA (1976) Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 144: 970–984
Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC (1996) Antibody response to a T-dependent antigen requires expression of complement receptors. J Exp Med 183: 1857–1864
Czop JK, Austen KF (1980) Functional discrimination by human monocytes between their Cab receptors and their recognition units for particulate activators of the alternative complement pathway. J Immunol 125: 124–128
Daffern PJ, Pfeifer PH, Ember JA, Hugli TE (1995) C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181: 2119–2127
Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT (1996) C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271: 348–350
Dierich MP, Ebenbichler CF, Marschang P (1993) HIV and human complement: mechanisms of interaction and biological implication. Immunol Today 14: 435–439
Duncan AR, Winter G (1988) The binding site for Clq on IgG. Nature 332: 738–740
Elsner J, Oppermann M, Czech W, Dobos G, Schopf E, Norgauer J, Kapp A (1994) C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 24: 518–522
Ember JA, Jagels MA, Hugli TE (1998) Characterization of complement anaphylatoxins and their biological responses. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, New York, pp 241–284
Ember JA, Sanderson SD, Hugli TE, Morgan EL (1994) Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144: 393–403
Engel P, Zhou L-J, Ord DC, Sata S, Koller B, Tedder TF (1995) Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3: 39–50
Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RAB (1996) The collectins in innate immunity. Curr Opin Immunol 8: 29–35
Fang Y, Xu C, Fu Y-X, Holers VM, Molina H (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160: 5273–5279
Fearon DT (1998) The complement system and adaptive immunity. Sem Immunol 10: 355–361
Fearon DT, Austen KF (1997) Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. Proc Natl Acad Sci USA 74: 1683–1687
Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272: 50–54
Fischer WH, Hugh TE (1997) Regulation of B cell functions by C3a and C3adesArg. J Immunol 159: 4279–4286
Fischer WH, Jagels MA, Hugh TE (1999) Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3adesArg. J Immunol 162: 453–459
Fischer MB, Goerg S, Shen LM, Prodeus AP, Goodnow CC, Kelsoe G, Carroll MC (1998) Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280: 582–585
Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC (1996) Regulation of B cell response to T-dependent antigens by classical pathway of complement. J Immunol 157: 549–556
Galdiero F, Tufano MA, Sommese L, Folgore A, Tedesco F (1984) Activation of complement system by porins extracted from S. typhimurium. Infect Immun 46: 559–563
Gerard NP, Gerard C (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349: 614–617
Goetzl EJ, Austen KF (1974) Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J Clin Invest 53: 591–599
Goldstein IM, Kaplan HB, Radin A, Frosch M (1976) Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol 117: 1282–1287
Hamilton KK, Hattori R, Esmon CT, Sims PJ (1990) Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265: 3809–3814
Hebell T, Ahearn JM, Fearon DT (1991) Suppression of the immune response by a soluble receptor of B lymphocytes. Science 254: 102–105
Heyman B, Wiesma EJ, Kinoshita T (1990) In vivo inhibition of antibody response by a monoclonal complement receptor specific antibody. J Exp Med 172: 665–668
Ishiguro H, Kobayashi K, Suzuki M, Titani K, Tomonaga S, Kurosawa Y (1992) Isolation of a hagfish gene that encodes a complement component. EMBO J 11: 829–837
Jackson CG, Ochs HD, Wedgewood RJ (1979) Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 300: 1124–1129
Kantor AB, Herznberg LA (1993) Origin of murine B cell lineages. Annu Rev Immunol 11: 501–538
Kishimoto TK, Jutila MA, Berg EL, Butcher EC (1989) Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245: 1238–1241
Klaus GG, Humphrey JH (1977) The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology. 33: 31–40.
Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT (1987) Human C3b/ C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of short consensus repeats characteristic of C3/C4 binding proteins. J Exp Med 165: 1095–1112
Krop I, de Fougerolles AR, Hardy RR, Allison M, Schlissel MS, Fearon DT (1996) Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol 26: 238–242
Kurtz CB, O’Toole E, Christensen SM, Weis JH (1990) The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1 J Immunol 144: 3581–3591
Li X, Carter RH (1998) Convergence of CD19 and B cell antigen receptor signals in the ERK2 activation cascade. J Immunol 161: 5901–5908
Liszewski M, Farries T, Lublin D, Rooney I, Atkinson J (1996) Control of the complement system. Adv Immunol 61: 201–283
Loos M, Wellk B, Thesen R, Opferkuch W (1978) Antibody-independent interaction of the first component of complement with gram-negative bacteria. Infect Immun 22: 5–9
Marschang P, Kruger U, Ochsenbauer C, Gurtler L, Hittmair A, Bosch V, Patsch JR, Dierich MP (1997) Complement activation by HIV-1 infected cells: the role of trans-membrane glycoprotein gp41. J Acquir Immune Defic Syndr Hum Retrovirol 14: 102–109
Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: a signal transducing complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173: 55–64
Merino S, Nogueras MM, Aguilar A, Rubires X, Alberti S, Benedi VJ, Thomas JM (1998) Activation of the complement classical pathway (Clq binding) by mesophilic Aeromonas hydrophila outer membrane protein. Infect Immun 66: 3825–3831
Molina H, Hollers VM, Li B, Fang Y-F, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93: 3357–3361
Moore MD, Cooper NR, Tack BF, Nemerow GR (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci USA 84: 9194–9198
Morgan EL, Weigle WO, Hugli TE (1984) Anaphylatoxin-mediated regulation of human and murine immune responses. Fed Proc 43: 2543–2547
Morgan EL, Thoman ML, Weigle WO, Hugli TE (1983) Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol 130: 1257–1261
Morgan EL, Sanderson S, Scholz W, Noonan DJ, Weigle WO, Hugh TE (1992) Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J Immunol 148: 3937–3942
Nataf S, Davoust N, Ames RS, Barnum SR (1999) Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 162: 4018–4023
Nepomucenco RR, Henschen-Edman AH, Burgess WH, Tenner Al (1997) cDNA cloning and primary structure analysis of ClqRp, the human Clq/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6: 119–129
Niculescu F, Rus H, van Biesen T, Shin ML (1997) Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J Immunol 158: 4405–4412
Nonaka M (1998) Phylogeny of the complement system. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, New York, pp 203–216
Nonaka M, Takahashi M (1992) Complete complementary DNA sequence of the third component of complement of lamprey. Implication for the evolution of thioester containing proteins. J Immunol 148: 3290–3295
Ochs HD, Wedgewood RJ, Frank MM, Heller SR, Hosea SW (1983) The role of complement in the induction of antibody responses. Clin Exp Immunol 53: 208–216
O’Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA (1988) Role of C3 in humoral immunity: defective antibody production in C3-deficient dogs. J Immunol 140: 1939–1945
Papamichail M, Gutierez C, Embling P, Johnson P, Holborow EJ, Pepys MB (1975) Complement dependence of localization of aggregated IgG in germinal centers. Scand J Immunol 4: 343–347
Pepys M (1972) Role of complement in induction of the allergic response. Nature New Biol 237: 157–159
Pereira P, Forni L, Larsson E-L, Cooper M, Heusser C, Coutinho A (1986) Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol 16: 685–688
Plumb ME, Sodetz JM (1998) Proteins of the membrane attack complex. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, Inc., New York, pp 49–82
Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352–355
Roberts T, Snow EC (1999) Recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J Immunol 162: 4377–4380
Ross SC, Densen P (1984) Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63: 243–273
Saadi S, Platt JL (1995) Transient pertubation of endothelial integrity induced by antibodies and complement. J Exp med 181: 21–31
Sastry K, Ezekowitz RA (1993) Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol 5: 59–66
Sato S, Steeber DA, Tedder TF (1995) The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92: 11558–11562
Schindler R, Lonnemann G, Hugli TE, Koch KM, Dinarello CA (1990) Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37: 85–93
Smith LC, Chang L, Britten RJ, Davidson EH (1996) Sea urchin genes expressed in activated coelomocytes are identified by expressed sequence tags. Complement homologues and other putative immune response genes suggest immune system homology within the deuterostomes. J Immunol 156: 593–602
Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE (1999) C-reactive protein: Structural biology and host defense function. Clin Chem Lab Med 37: 265–270
Takabayashi T, Vannier E, Clark BD, Margolis NH, Dinarello CA, Burke JF, Gelfand JA (1996) A new biologic role for C3a and C3a desArg. Regulation of TNF-a and IL-l13 synthesis. J Immunol 156: 3455–3460
Tedder TF, Inaoki M, Sato S (1997) The CD19–CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6: 107–118
Tenner AJ, Robinson SL, Ezekowitz RAB (1995) Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126000 Mr component of the C l q receptor. Immunity 3: 485–493
Thyphronitis G, Kinoshita T, Inoue K, Schweinle JE, Tsokos GC, Metcalf ES, Finkelman FD, Balow JE (1991) Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 147: 224–230
Turner MW (1996) Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17: 532–540
Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT (1991) Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/ CD19 complex. J Exp Med 173: 1083–1089
Volanakis JE (1982) Complement activation by C-reactive protein complexes. Ann NY Acad Sci 389: 235–250
Volanakis JE (1990) Participation of C3 and its ligands in complement activation. Curr Top Microb Immunol 153: 1–21
Volanakis JE (1998) Overview of the complement system. In: Volanakis JE, Frank MM (eds) The human complement system in health and disease. Marcel Dekker, New York, pp 9–32
Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT (1988) Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med 167: 1047–1066
Wittmann M, Zwirner J, Larsson V-A, Kirchhoff K, Begemann G, Kapp A, Götze O, Werfel T (1999) C5a suppresses the production of IL-12 by IFN-y-primed and lipopolysacharidechallenged human monocytes. J Immunol 162: 6763–6769
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Volanakis, J.E. (2002). The Role of Complement in Innate and Adaptive Immunity. In: Cooper, M.D., Koprowski, H. (eds) The Interface Between Innate and Acquired Immunity. Current Topics in Microbiology and Immunology, vol 266. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04700-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-04700-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07682-4
Online ISBN: 978-3-662-04700-2
eBook Packages: Springer Book Archive